Cell Therapy Instruments Market Size, Growth, Share 2021-2031
Le marché des instruments de thérapie cellulaire était évalué à 15,15 milliards de dollars américains en 2021 et devrait atteindre 59,98 milliards de dollars américains d’ici 2031. Le marché devrait enregistrer un TCAC de 15,4 % en 2023-2031. Le passage à la fabrication automatisée restera probablement une tendance clé du marché des instruments de thérapie cellulaire.
Analyse du marché des instruments de thérapie cellulaire
La thérapie cellulaire consiste à injecter, implanter ou greffer des cellules vivantes et intactes dans le corps du patient. Par exemple, une personne atteinte d’un cancer reçoit une injection de lymphocytes T au cours de son immunothérapie. La livraison d'instruments de thérapie cellulaire va de l'injection à l'implantation chirurgicale à l'aide de dispositifs spéciaux. La thérapie cellulaire trouve des applications dans un grand nombre de pathologies. Les maladies du système nerveux les plus importantes sont le cancer. D'autres applications incluent les maladies cardiaques (infarctus du myocarde et insuffisance cardiaque), le diabète sucré, les os et les articulations, les troubles génétiques et les plaies de la peau et des tissus mous.
Aperçu du marché des instruments de thérapie cellulaire
L’une des méthodes les plus prometteuses pour traiter le cancer est la thérapie par cellules T du récepteur d’antigène chimérique (CAR), et chaque année, un nombre considérable d’essais précliniques et cliniques sont menés pour accroître son application. Après des décennies de recherche, la thérapie cellulaire CAR-T va inévitablement se développer. Outre les produits autologues et allogéniques , de nouvelles thérapies géniques cellulaires CAR-T in vivo et leur efficacité dans des indications autres que les hémopathies malignes seront également étudiées dans l'avenir des thérapies cellulaires.
Personnalisez la recherche en fonction de vos besoins
Nous pouvons optimiser et adapter l’analyse et la portée qui ne sont pas satisfaites par nos offres standard. Cette flexibilité vous aidera à obtenir les informations exactes nécessaires à la planification de votre entreprise et à la prise de décision.
Marché des instruments de thérapie cellulaire : perspectives stratégiques
TCAC (2023 - 2031)15,4%- Taille du marché 2021
15,15 milliards de dollars américains - Taille du marché 2031
59,98 milliards de dollars américains
Dynamique du marché
- Développements croissants dans la fabrication de thérapies cellulaires
- Passage à la fabrication automatisée
- Opportunités de croissance dans les régions en développement
Joueurs clés
- Thermo Fisher Scientific Inc.
- MERCK KGaA
- Lonza
- Cytiva (GE Healthcare Life Sciences)
- Terumo Corporation
- BD
- Miltenyi Biotec
- STEMCELL Technologies Inc.
- Sartorius AG
- Danaher Corporation (Beckman Coulter Inc.)
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product - Consumables
- Equipment
- Systems and Software; Cell Type
Cell Type - Human Cells
- Animal Cells
Process - Cell Processing
- Process Monitoring and Quality Control
- Cell Preservation
- Distribution
- Handling
End User - Research Institutes
- Life Science Research Companies
- Other End Users
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Cell Therapy Instrument Market Drivers and Opportunities
Increasing Developments in Cell Therapy Manufacturing
The increasing research activities in cell therapy have led to extraordinary therapeutic developments in cell therapy instruments to treat genetic disorders and improve the immune system efficiently. Various market players provide consumables such as reagent kits and enzymes, and many companies offer instruments, equipment, and software to conduct a wide range of cell therapy processes.
Equipment use is important for producing cell therapies such as T cells, HSC, MSC, PSC, and NSC. These cell therapy products are derived from human or animal cells and thus require safe conditions from contamination. Thus, the instruments used for cell therapies help prevent contamination and allow scaling up the production. For instance, companies such as Corning Incorporated, Hitachi Chemical Advanced Therapeutics Solutions, LLC, Cytiva (General Electric Company), Thermo Fisher Scientific Inc., Invetech, and Miltenyi Biotec have introduced various instruments and consumables for cell therapy.
Growth Opportunities in Developing Regions– An Opportunity in the Cell Therapy Instruments Market
The biotechnology sector in Asia Pacific and Middle East is growing rapidly with the support of heavy investments and strategic developments among private and public organizations with countries in North American and European regions. For instance, in December 2019, Astellas Pharma Inc (Japan) signed an agreement to acquire Audentes Therapeutics Inc., a gene therapy company, for US$ 3 billion. Similarly, in November 2019, Fujifilm planned to invest ~US$ 120 million (13 billion yen) in gene therapy as a part of contract development and manufacturing segment of the organization. Also, the Japan Pharmaceutical Medical Device Agency (PMDA) approved two gene therapy products. The products were approved simultaneously under Sakigake designation, which is equivalent to the FDA breakthrough therapy designation and the EMA Priority Medicine (PRIME) designation and is expected to approve at least one therapy per year. Such strategic developments by the domestic players in the Asian countries for cell therapy domain are likely to increase demand for cell therapy instruments in coming future.
Cell Therapy Instrument Market Report Segmentation Analysis
Key segments that contributed to the derivation of the cell therapy instrument market analysis are disorder and service providers.
- Based on products, the cell therapy instrument market is segmented into consumables, equipment, systems and software. The consumables segment held a larger market share in 2023.
- By cell type, the cell therapy instrument market is segmented into human cells, animal cells. The thermoplastics segment held the largest share of the market in 2023.
- By process, the cell therapy instrument market is segmented into cell processing, process monitoring and quality control, cell preservation, distribution, and handling. The cell processing segment held the largest share of the market in 2023.
- By end users, the cell therapy instrument market is segmented into research institutes, life science research companies, other end users. The life science research companies segment held the largest share of the market in 2023.
Cell Therapy Instrument Market Share Analysis by Geography
The geographic scope of the cell therapy instrument market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.
The US is the largest and fastest-growing market for cell therapy instruments. The market growth is attributed to increased R & D and the growing adoption of cell therapies such as gene, stem cell, and immune therapies. In addition, increasing support from the government is enhancing the growth of cell therapies, influencing the market's growth. For instance, the American Society of Gene & Cell Therapy (ASGCT), a public organization, provides memberships to scientists, physicians, professionals, and patient advocates engaged in gene and cell therapies. ASGCT aims to enhance knowledge, education, and awareness regarding the clinical application of cell and gene therapies.
Cell Therapy Instrument Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 15.15 Billion |
| Market Size by 2031 | US$ 59.98 Billion |
| Global CAGR (2023 - 2031) | 15.4% |
| Historical Data | 2021-2022 |
| Forecast period | 2023-2031 |
| Segments Covered | By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Cell Therapy Instrument Market News and Recent Developments
The cell therapy instrument market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for foot orthotic insoles:
- Thermo Fisher Scientific and robotics expert Multiply Labs signed an agreement to further their collaboration to automate cell therapy production. (Source: Thermo Fisher Scientific, 2024).
- To provide a unified technological platform for next-generation cellular therapies from concept to commercialization, MaxCyte launches the ExPERT instrument family. (Source: MaxCyte, Press Release, 2019).
Cell Therapy Instrument Market Report Coverage and Deliverables
The “Cell Therapy Instrument Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Dynamique du marché telle que les moteurs, les contraintes et les opportunités clés
- Principales tendances futures
- Analyse détaillée des cinq forces et SWOT de PEST/Porter
- Analyse du marché mondial et régional couvrant les principales tendances du marché, les principaux acteurs, les réglementations et les évolutions récentes du marché
- Analyse du paysage industriel et de la concurrence couvrant la concentration du marché, l’analyse des cartes thermiques, les principaux acteurs et les développements récents
- Profils d'entreprises détaillés
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For